MEM — Memphasys Income Statement
0.000.00%
HealthcareSpeculativeMicro CapSucker Stock
- AU$13.43m
- AU$16.65m
- AU$0.03m
Annual income statement for Memphasys, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.027 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 0.008 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.401 | 1.04 | 1.13 | 1.49 | 1.59 |
Operating Profit | -0.401 | -1.04 | -1.13 | -1.49 | -1.57 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.401 | -1.04 | -1.13 | -1.49 | -2.08 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.401 | -1.04 | -1.13 | -1.49 | -2.08 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.401 | -1.04 | -1.13 | -1.49 | -2.08 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.401 | -1.04 | -1.13 | -1.49 | -2.08 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.002 | -0.001 | -0.002 | -0.003 |